TSLP and metabolic dysfunction-associated steatohepatitis: The results showed that overexpression of miR-142-5p resulted in a decrease in the expression of TSLP and a certain degree of reversal of liver damage caused by NASH, and the therapeutic effect of the experimental group after additional addition of TSLP was attenuated or even disappeared.